Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
Completed · Not applicable
Conditions studied: Management of Anticoagulation
In brief
Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation. Until recently, the testing of the level of anticoagulation was performed at medical laboratories or hospitals. The purpose of this study is to see if patients who test their level of anticoagulation by themselves at home and then call their doctor with the result have better control of their anticoagulation as compared to patients whose anticoagulation is checked only by their physician.
Key facts
- Study ID
- NCT00703963
- Run by
- Mayo Clinic
- People needed
- 200
- Starts
- 2007-03-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2014-08-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients that received a mechanical valve while in our hospital
- Age > 18 years
You may not qualify if…
- Pregnant or lactating women
- Patients that have genetic clotting disorders such as Factor 5
- Physical disabilities (for example, poor eyesight, tremor, or other neurological disability) that would prevent the patient from being able to perform finger stick blood sampling. (Patients may not be excluded for physical disabilities if a care giver is willing to learn and assist with performing patient self-testing.)
Where it is running
- Saint Marys Hospital — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.